In the dynamic landscape of modern health, cardiovascular diseases rank as the foremost global causes of mortality. From exploring the intricate connections between chronic inflammation and the development of cardiovascular conditions, to investigating how impaired mitochondrial function contributes to the onset and progression of heart failure, researchers are navigating the complexities of cardiovascular disease progression to address critical aspects of cardiovascular health.
Cardiovascular treatment is dependent on the cause and the extent of heart damage. While healthy lifestyle, medication and even surgery are common treatments, stem cell therapy development has been emerging as a dynamic frontier, where scientific investigation converges with therapeutic innovation. This multidisciplinary approach holds the promise of reshaping the landscape of cardiovascular care, offering novel strategies to enhance cardiac repair and improve patient outcomes.
Regardless of your focus within cardiovascular research, Enzo offers innovative tools designed to accelerate discoveries through our patented technologies and robust manufacturing capabilities. With over 45 years of expertise and collaboration with scientists across the globe, Enzo provides unique solutions that will propel the progress of cardiovascular research. Our extensive product catalog reflects our commitment to providing the necessary tools and support that enable your groundbreaking discoveries.
Vascular growth and regeneration are fundamental processes in the maintenance and repair of the circulatory system.
Mitochondrial dysfunction and mitochondrial membrane potential cytotoxicity can lead to damaging protein, lipids, and/or nucleic acids macromolecules.
Chronic inflammation is recognized as a key contributor to the development of cardiovascular diseases.
Mitochondria play a crucial role in the energy metabolism of cardiac cells, and their dysfunction has been implicated in heart failure.
Cellular therapy is a novel approach to treat cardiovascular diseases.
Biomarkers play a crucial role in risk assessment, diagnosis, and in monitoring treatment response of cardiovascular conditions.
Vascular growth and regeneration are fundamental processes in the maintenance and repair of the circulatory system. Vascular growth, also known as angiogenesis, is a complex and tightly regulated process that occurs during development, and under various physiological and pathological conditions. It also plays a pivotal role in cardiovascular diseases and cancer growth.
Vasopressin, also known as arginine vasopressin (AVP) or [Arg8]-Vasopressin, is a peptide hormone produced by the hypothalamus and released by the posterior pituitary gland, to regulate osmotic balance, sodium homeostasis, kidney function, and blood pressure. Recent studies explore the potential role of vasopressin as a pro-angiogenic factor that reduces cardiovascular damage.
The highly sensitive [Arg8] Vasopressin ELISA Kit can measure this critical peptide hormone involved in blood vessel constriction, and linked to several cardiovascular processes. For instance, this assay can detect elevated levels of AVP in plasma samples, in cases of ischemic cardiomyopathy, for the study of chronic congestive heart failure.
High Sensitivity Detection of [Arg8] Vasopressin
Standard curve for the detection of as little as 2.84 pg/ml of [Arg8] Vasopressin.
Calcium plays a crucial role in the contraction of heart muscles, and the process of calcium mobilization in cardiac muscle cells is highly investigated. Dysregulation in calcium handling, whether due to genetic mutations or other factors, can lead to arrhythmias and impair cardiac function. Fluorescent calcium indicators are used to monitor changes in intracellular calcium levels, allowing real-time visualization.
Enzo’s FLUOFORTE® dyes are optimized for high throughput detection of intracellular calcium in living cells such as cardiomyocytes as well as characterized second messenger commonly used to monitor G-protein-coupled receptors activation in primary screening.
2X brighter dye than Fluo-4 for Superior Detection of Calcium Mobilization
FLUOFORTE® exhibits significantly brighter fluorescence intensity than Fluo-3 AM and Fluo-4 AM. U-2 OS cells were seeded overnight, growth medium was removed, and cells were incubated with 100 µL of FLUOFORTE® AM, Fluo-3 AM, or Fluo-4 AM in HHBS at 37 °C, 5% CO2 incubator for 1 hour. The cells were washed twice with 200 µL HHBS, and ATP (20 µL/well) was added to achieve concentrations of 200 nM with dye efflux inhibitor. Cells were then immediately imaged with a fluorescence microscope (Olympus IX71) using FITC channel.
Chronic inflammation is recognized as a key contributor to the development of various cardiovascular diseases, including atherosclerosis and coronary artery disease. Inflammatory processes can lead to the formation and progression of atherosclerotic plaques in blood vessels.
In chronic inflammation and cardiac physiology studies, the PGE2 ELISA Kit is used to detect and quantify PGE2 as a marker of cardiac function.
Ultrasensitive ELISA Kit for detection of PGE2
Standard curve showing that PGE2 ELISA Kit can detect as little as 8.26 pg/ml of protein
Mitochondria play a crucial role in the energy metabolism of cardiac cells, and their dysfunction has been implicated in heart failure. Cyclic adenosine monophosphate (cAMP) is a signaling molecule that is involved in various cellular processes, including regulating cardiac contractility, heart rate, and other processes. Medications like beta-adrenergic receptor blockers and phosphodiesterase inhibitors modulate cAMP levels.
Complete colorimetric kit for intracellular and extracellular quantification of cAMP
Proven Consistency with Lot-to-Lot Performance
Lot-to-lot consistency: Graph demonstrates the robust and reproducible nature of the competitive cAMP ELISA Kit showing standard curves from 10 lots manufactured over 10 years.
Cellular therapy has been often proposed as a critical approach to treat cardiovascular diseases. Stem cells, especially mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs) are explored as a regenerative approach for cardiovascular conditions. Cell-based cardiovascular therapy research and development aim to refine techniques, expand indications, and establish the long-term safety and efficacy of these treatments.
Our cardiotoxicity compound library is an essential tool used for high-throughput screening to identify potential targets for cellular therapy research, and as predictive toxicology screening to assess safety in cellular therapy development.
Cardiac disease biomarkers play a crucial role in cardiovascular diagnosis, risk assessment, and in monitoring treatment response. 25(OH) Vitamin D, also known as calcidiol, plays a role in various physiological processes, including cardiovascular health. Recent studies suggested that lower levels of vitamin D may be associated with an increased risk of heart disease and hypertension.
The 25(OH)-Vitamin D assay is quick and accurate, making it the tool of choice for 25(OH)-Vitamin D detection.
Ultrasensitive Detection of 25(OH) Vitamin D
Standard curve for the detection of 25(OH) Vitamin D.
Cardiovascular disease is consistently ranked as the single largest cause of death in the world, and it may be caused by heart damage or vascular problems. Challenges in cardiovascular clinical development have caused researchers to take a closer look at cardiac function and metabolism. Enzo Life Sciences offers a comprehensive portfolio of products to enable discovery of cardiac risk factors as well as analysis of the cellular response to novel therapeutics for cardiovascular medicine.
From target discovery and validation to formulation and manufacturing, Enzo offers a line of products and services that can accelerate your cardiovascular program. Choose from an extensive range of assay kits, enzymes, substrates, and compound libraries for primary and secondary screening, immunodetection assays for reliable biomarker detection, and cytotoxicity assays for in vitro drug safety assessment. Our aim is to deliver innovative tools that make cardiovascular research more efficient, cost-effective and successful.
